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Sensorineural non-syndromic hearing loss is the most common disorder which affects 1 in 500 newborns. 
Hearing loss is an extremely heterogeneous defect with more than 100 loci identified to date. According to the 
studies, mutations in GJB2 are estimated to be involved in 50- 80% of autosomal recessive non-syndromic 
hearing loss cases, but contribution of other loci in this disorder is yet ambiguous. With regard to studies, 
DFNB4 locus (SLC26A4) can be classified as the second cause of hearing loss. So, this study aimed to determine 
the contribution of this locus in hearing loss as well as the frequency of SLC26A4 gene mutations in a 
population in the west of Iran. In this descriptive laboratory study, we included 30 families from the west of Iran 
with no mutation in GJB2 gene. Linkage analysis was performed by DFNB4 (SLC26A4) molecular markers 
(STR). The families with hearing loss linked to this locus were further analyzed for mutation detection. 
SLC26A4 gene exons were amplified and analyzed using direct DNA sequencing. In studied families, 2 families 
displayed linkage to DFNB4 locus. Identified mutations include mutation in exon 5 (c.416 G>T) and in splicing 
site of exon 7 (IVS-2 A>G or c.919-2 A>G). 
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utosomal recessive non- syndromic hearing 
loss (ARNSHL) is the most common defect 
at birth, which affects 1 in 500 newborns (1). 
Deafness is a heterogeneous disorder and can occur 
due to genetic factors or environmental factors or 
both (2). Over 50% of hearing loss (HL) causes are 
attributed to genetic factors of which 70% are non-
syndromic (3). Up to now, more than 60 genes have 
been identified for non- syndromic hearing loss (4). 
Since HL is highly heterogeneous, researchers 
suggest  studying large size families with different 
ethnicities such as the Middle East populations (5). 
A
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Based on these studies, DFNB1 locus is the most 
common cause of HL and accounts for up to 50% 
of cases in Asia, Europe and northern America (6). 
Studies in Iran also have indicated that the 
contribution of GJB2 gene in HL in different 
ethnicities in Iran is different ranging from 27-38% 
in a population of north of Iran to 0-4% in the south 
east of Iran (7, 8). Up to now, the relative 
contribution of mutations in other genes associated 
with HL has been identified only in the limited 
number of Iranian families. To determine the exact 
contribution of each of these genes in Iranian 
families, more comprehensive studies are required 
(9-11). For recessive deafness, the most frequ- 
ently involved genes include GJB2, SLC26A4, 
MYO15A, OTOF, CDH23 and TMC1 worldwide. 
SLC26A4 gene at DFNB4 locus is the second 
leading cause of HL. This gene consists of 21 exons 
and is located at 7q22-q31 (DFNB4), encoding 
Pendrin. Pendrin is an iodide/ chloride transporter 
that is expressed in cochlea, thyroid and kidney. 
This protein transports anions such as HCO, OH-, I-. 
Mutation in this gene is the second cause of HL 
which can cause ARNHL and Pendred Syndrome 
(PS). Signs and symptoms in PS are profound 
sensorineural HL along with enlarged thyroid or 
small sized thyroid. DFNB4 and PS  have been seen 
in 1-8% of prelingual hearing loss cases (9). 
Mutations in this gene have been reported  
in different American, European and Asian 
populations such as Iran (12, 13). So far, more than 
200 mutations in SLC26A4 gene have been 
identified which are scattered in the whole gene and 
most of them are missense (http://www.healthcare-
uiowa.edu/labs/pendredandbor/slcMutations.htm). 
These mutations are the most common causes of 
ARNHL in Iran and worldwide after GJB2 (14). 
This study aimed to determine the frequency of 
mutations and perform an analysis of the locus, due 
to the importance of DNBF4 after DNBF1 locus 
and also the frequency of mutations in studied 
cohort. 
Material and Methods 
In this descriptive laboratory study, 
informational questionnaires were filled out and 
clinical evaluations were performed. We included 
30 families with at least 2 ARNHL individuals from 
the western provinces of Iran with no Connexin 26 
mutation detected in a previous research (7). After 
obtaining written consent from patients and their 
families, 5 ml peripheral blood from all members of 
families in tubes containing 0.5M EDTA. Genomic 
DNA was extracted from blood samples using 
standard phenol-chloroform protocol. The quantity 
and quality of extracted DNA were evaluated by 
using a spectrophotometer (UNICO 2100, USA) 
(15). For linkage analysis of the locus, 4 different 
STR markers were used. Upon encountering an 
uninformative marker, further markers were 
genotyped. The used markers and their charact-
eristics are shown in table 1. The criteria for 
selecting these markers include greater 
heterozygosity values, shorter amplicon and 
locating near the known locus. Choice of STRs and 
their primers were based on their physical distance 
in NCBI Map Viewer and NCBI UniSTS. 
Polymerase chain reaction (PCR) amplification of 
markers, touchdown program was carried out with 
conditions described previously (16). For S-Link 
and LOD score calculation, the Easylinkage plus 
genetic software version 5.05 was used (17). To 
calculate S-Link, FastSlink version 2.51 was used. 
Two point and multi-point parametric LOD scores 
were calculated by Superlink version 1.6 and 
Genehunter version 2.91. For LOD score 
calculations, inheritance pattern of autosomal 
recessive, complete penetrance and allele frequency 
of 0.001 were assumed. Haplopainter software 
version 029.5 was used for reconstruction of 
haplotypes (18). For mutation analysis, 21 exons 
and intron-exon boundaries of SLC26A4 gene were 
amplified using specific designed primers (19). 
Reaction conditions for amplification of exons in a 
volume of 50 µL were as follows: 5 µL 10x PCR  
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buffer, 2 µL of 50 mM MgCl2, 1 µL of 10 mM 
dNTPs mix, 0.5 µL of each 50 pM forward and 
reverse primers, 2 µL of genomic DNA (100ng  ) and 
finally 0.5 U of Taq DNA polymerase enzyme. 
PCR was performed with following conditions: an 
initial denaturation at 95 ºC for 5 min followed by 
next 35 cycles of 94 ºC for 1 min (denaturation), 
annealing at 58-62 ºC (depending on exon) for 1 
min, 72 ºC for 1 min (extension) and final extension 
at 72 ºC for 5 min. To detect any variant in the gene 
sequence, direct sequencing of amplified exons was 
performed bidirectionally using ABI 3730XL 
sequencing instrument. 
 
Results 
In this study, most of the subjects displayed 
bilateral, severe to profound sensorineural HL, and 
most of families were consanguineous. In haplotype 
analysis, 2 families from Hamedan province 
showed linkage to the DFNB4 locus (fig. 1). Two 
point and multi point LOD and S-link scores related 
to these families are indicated in Table 2. Linkage 
to the locus was confirmed by molecular markers 
on electrophoresis gel (fig. 2). The molecular 
analysis of the SLC26A4 gene disclosed 2 variants 
in exons 7 and 5 in homozygous state in Family 14 
and 9, respectively. Exon 5 variant was missense 
substitution and substitute G for T in 416 location 
of coding region of SLC26A4 gene (c.416 G>T) 
which cause to change glycine to valine (P.G139V). 
Exon 7 variant is in splicing site which substitute A 
for G (IVS-2 A>G or c.919-2 A>G) and produce 
defective protein (fig. 3). 
 
Discussion 
In this investigation, 2 families out of 30 
families (~ 7%) were found to be linked to DFNB4 
locus (SLC26A4 gene). We detected two variants 
(c.416 G>T and c.919-2 A>G) in two families 
linked to DFNB4 locus. c.416 G>T is a missense 
substitution which causes a change of glycine to 
valine (G139V). This amino acid residue is highly 
conserved among species and is located in the third 
transmembrane domain of Pendrin. Thus, structural 
change can be expected to be deleterious for the 
protein function. Probably mutant Pendrin proteins 
are retained in the intracellular region and/ or 
distributed in endoplasmic reticulum, while wild 
proteins reach the plasma membrane (20, 21). 
Sequence analysis of SLC26A4 gene in 46 families 
in Pakistan showed this mutation as a novel variant 
(12). The other variant, c.919-2 A>G, was first 
identified in a Turkish family (22) and subsequently 
reported in deaf individuals from Japan, Korea and 
China (13, 23). This mutation causes the removal of 
splicing site with a resulting stop codon at position 
311, resulting in a truncated protein (24). 
Other studies concluded that approximately 
5% of ARNHL cases in south Asia and other 
populations are due to mutation in SLC26A4 gene 
(13, 25). Pera et al. in 2007 identified 24 mutations 
in SLC26A4 gene in 105 Spanish  affected  subjects  
Table 1. STR markers used and their characteristics. 
STR Forward primer  
(5'  3') 
Reverse primer  
(5'  3') 
Size (bp) Heterozygosiy 
D7S2420 CCTGTATGGAGGGC
AAACTA 
AAATAATGACTGAGGCT
CAAAACA 
240-292 0.81 
D7S2459 CAGAACTATTATTTA
GGAG 
TAGTAAAACCCATTTGAA
G 
145-165 0.77 
D7S2456 CTGGAAATTGACCTG
AAACCTT 
ACAGGGGTCTCTCACACA
TATTA 
238-252 0.63 
D7S496 AACAACAGTCAACC
CACAAT 
CTATAACCTCATAANAAA
CCAAAA 
129-141 0.74 
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Fig. 1. Pedigree and haplotype of Iranian family 9 (IF9) and Iranian family 14 (IF 14). The order of markers is based on the Marshfield 
map. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
and 20 families with ARNHL linked to the locus 
(26). Lee et al. in 2007 performed DNA sequencing 
of SLC26A4 gene in 7 affected subjects with inner 
ear malformation with EVA and identified 3 
different variants. Based on the results of this study, 
GJB2 and SLC26A4 mutations are major causes of 
Table 2. S-Link and LOD scores calculated for families linked to DFNB4. 
Family S-LINK Two point LOD score  Multipoint LOD score 
Iranian Family 14 (IF14) 3.28 2.25 2.61 
Iranian Family 9 (IF9) 1.45 1.08 1.17 
The Linkage Analysis Study of SLC26A4 Gene 
180   Int J Mol Cell Med Summer 2014; Vol 3 No 3 
Fig. 2. Polyacrylamide gels for D7S2459 marker. Section 1 corresponds to the IF14 (lane 1: size marker, lane 2: mother, lane 4: healthy 
child, lanes 3, 5, 6 and 7: affected children) and section 2 is related to IF9 (lane1: father, lane 2: mother, lanes 3 and 4: healthy children, 
lanes 5 and 6: affected children). 200 bp 
Fig. 3. Chromatograms of SLC26A4 variants. A: normal alleles for c.416 G>T. B: mutant allele of c.416 G>T. C: normal individual for IVS-
2 A>G. D: mutant allele for IVS-2 A>G. 
congenital hearing loss in Korea (27). In Iran, also 
several investigations have been carried out to 
analyze this gene; Sadeghi et al. in 2008 performed 
linkage analysis of four DFNB loci and mutations 
in GJB2 in 40 families with ARNHL from west of 
Iran, 3 families showed linkage to the DFNB4 locus 
(28). In one study by Kahrizi et al. in 2008, out of 
80 Iranian families with ARNHL, 12 were found to 
be linked to DNBF4 locus, 8 mutations were 
detected by DNA sequencing of SLC26A4 gene (9). 
Tabatabaeifar et al. in 2009 investigated 30 families 
with non-syndromic HL using linkage analysis and 
found that 3 families were linked to the DFNB4, 
Therefore, the frequency of this locus in non-
sydromic, HL was estimated to be 10% (16). 
Recently in a research by Yazdanpanahi et al., out 
of 30 studied families, 3 (10%) were found to be 
linked to DFNB4 (19). 
Identified mutations in this study were either 
missense which alters one amino acid resulting in 
the loss of proper function of protein or splice 
mutation which leads to defective protein. Up to 
date, more than 200 mutations in SLC26A4 gene 
have been identified. The majority of these 
mutations are missense, each of them affecting the 
different stages of transcription, translation, 
processing or protein function. Different studies 
have revealed that mutations associated with PS 
cause loss of transporting ability of protein while 
mutations associated with DFNB4 affect the protein 
function (such as reducing protein function)  
(29, 30). 
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According to the studies carried out in 
different populations worldwide as well as Iran, 
SLC26A4 ranked as the second cause of ARNHL. 
Despite extensive studies on DFNB4 locus and 
SLC26A4 gene, still there are so many ambiguities 
about different mutations in this gene and their 
frequency in Iran that may be due to Iranian 
different ethnicities, allelic heterogeneousity and 
the large size of the gene. Therefore, these studies 
help in further understanding of this gene for 
clinical decision making and counseling of 
members of affected families. 
Our present investigation illustrates that in 7% 
of studied families, HL was associated with 
SLC26A4 gene. However, the cause of HL in the 
remaining 93% families is still unknown and more 
extensive studies may be necessary. Correspond-
ingly, in order to gain more information on the 
exact molecular bases of HL, further studies on the 
different populations and other loci for the same 
populations have to be performed. 
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